Litigation Details for Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket		Date Filed	2018-12-19
Court	District Court, D. Delaware	Date Terminated	2020-05-04
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	7,767,851; 8,093,423; 8,299,298; 8,338,642; 8,609,896; 8,754,257; 8,754,258; 8,846,976; 8,901,349; 9,050,316; 9,328,133; 9,387,191; 9,757,416
Link to Docket	External link to docket

Details for Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-12-18	1		United States Patent Nos. 7,767,851 (the “’851 patent”); 8,093,423 (the “’423 patent”); 8,299,298 (the…(the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896 patent”); 8,754,257 (the “’257…’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent”); 8,901,349 (the “’349 patent…25 PageID #: 2 patent”); 9,328,133 (the “’133 patent”); 9,387,191 (the “’191 patent”); and 9,757,416… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C	External link to document
2019-04-10	17	Complaint - Amended	United States Patent Nos. 7,767,851 (the “’851 patent”); 8,093,423 (the “’423 patent”); 8,299,298 (the…(the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896 patent”); 8,754,257 (the “’257…’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent”); 8,901,349 (the “’349 patent…9,050,316 (the “’316 patent”); 9,328,133 (the “’133 patent”); and 9,757,416 (the “’416 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C	External link to document